Danube S3-Common actions and synergies in health

Transregional Network for Innovation and Technology Transfer to Improve Health CareRete transregionale per l’innovazione ed il trasferimento tecnologico per il miglioramento della sanitàTransregionalno omrežje za inovacijo in prenos tehnološkega znanja za izboljšanje zdravstva

Suggestions for: Exploitation of synergies, common actions and new project ideas for Danube RIS3 – priority HEALTH

Sabina Passamonti University of Trieste, Lead Partner Danube S3 Workshop: “Gathering opportunities

around RIS3 priorities” at Austrian Federal Ministry of Science, Research and

Economy, Freyung 3, 1014 Vienna 07.07.2015

What is the Danube S3 Workshop? See below or read more in http://s3platform.jrc.ec.europa.eu/s3-in-danube-vienna-2015  

Thematic discussion group Health

“The workshop participants were divided in the smaller thematic discussion groups on ICT, health, energy and

sustainable innovation where 16 new project ideas were explored to start collaboration in S3 priorities.”

All other project ideas are available in: http://s3platform.jrc.ec.europa.eu/s3-in-danube-vienna-2015

Trans2Care project ideas and collaboration areas are presented here.

What future for Trans2Care?  

•  Replication? (we again …) •  Imitation? (the others … here and elsewhere)

•  Transposition? (the others … elsewhere)

•  Evolution? (another thing…)

What future for Trans2Care? - some answers  •  Replication

–  No, Trans2Care is not perfect; many pitfalls.

•  Imitation –  We do not recommend; pitfalls2 (no experience x

pitfalls imitation)

•  Transposition –  Careful: there are regional specificities

•  Evolution –  We recommend à amplification of opportunities

How to evolve?  

GENERAL OBJECTIVE Improve the capacity to push research results into innovation

ACTIONS NEEDED  

1.  Refinement and development of the strategic core of Trans2Care •  More solutions to closely link research with

innovation

2.  More efficient and coordinated thematic research activities •  More results that can be directly taken up

by hospitals, care services, SMEs, schools and public authorities

PRODUCTS  tools,  guidelines,  

advices,  networking,  …  

Trans2Care natural evolution in INTERREG Programmes  

CORE  STRATEGIC  PROJECT    developing  solu-ons  for  linking  biomedical  research  results    with  

innova-on  

RESULTS    Efficient  R&I    by  thema5c  projects  

NeurodegeneraBve  diseaeses  

Cancer  diseaeses  

Cardiovascular  diseaeses  

Airways  and  pulmonary  diseaeses  

Metabolic  diseaeses  

SUPPORT  FOR  &  IMITATION  BY  FOCUSSED,  THEMATIC  PROJECTS    

 BIG  LP  EFFORT  

CAPITALISATION  WITH  Pacinno  project  (IPA-­‐Adria-c  2007-­‐2013)  RegHealth-­‐RI  project  

(Horizon  2020)    

TARGET  3  Quality  of  

research-­‐industry  interplay    

Currently under evalutation  

TARGET  2  Quality  of  insBtuBons  

TARGET  1  Quality  of  human  

capital  OUTPUTS    TRAINING  TOOLS    

ACTION  PLANS  STRATEGY  PAPERS  

             RESULTS      

Biomedical  researchers  at  ease  both  in  the  lab  and  

with  entrepresises  and  public  authoriBes.  CreaBve  

relaBonships    

Why this special evolution?  

Let some figures speak by themselves. Look at our survey results.

Our simple survey  •  Title: “Survey on joint applications to Interreg and

Horizon 2020 programmes-Health Topics” •  10 Questions •  Sent to ca. 300 persons:

–  Registered attendees of former Italy-Slovenia Cross-border Biomedical Conference (27.02.2014) (http://www.trans2care.eu/Sections.aspx?section=510.595)

–  Professors and post-doc fellows of Dept. of Life Sciences –  Trans2Care Partners

•  Open 30.06.2015-06.07.2015 •  52 RESPONDENTS

The 10 questions of the survey  1.  Can you list some key words describing your research expertise? 2.  How would you describe your availability of research staff? 3.  How would you describe the size of your grants? 4.  What kind of funds do you usually get for your research? 5.  What are your research objectives? 6.  How severe is your shortage of funds? 7.  Are you short of research staff? 8.  Are you short of administration support? 9.  How do you bypass the factors (funds, research and administrative

staff) that challenge your research? 10. What role do you prefer in a collaborative project?

DATA ANALYSIS

RESEARCH EXPERTISE  

19,61%&

15,69%&

11,76%&

37,25%&

19,61%&

0%& 5%& 10%& 15%& 20%& 25%& 30%& 35%& 40%&

I&have&no&staff,&I&work&alone&

I&have&only&pre=graduate&students&

I&have&only&PhD&student(s)&

I&have&a&non=permanent&research&team&(PhDs&and&post=docs)&

I&have&a&stable&research&team&

My#research#staff#

Funds and human capital baseline  

30,00%%

44,00%%

16,00%%

14,00%%

0,00%%

0%% 5%% 10%% 15%% 20%% 25%% 30%% 35%% 40%% 45%% 50%%

None%

Small%grants%(ca.%20.000%€/year)%

Medium%grants%(ca.%80.000%€/year)%

Large%grants%(ca.160.000%€/year)%

I%have%no%needs%for%the%next%3%years%

My#usual#research#grants#

0,00%$

10,00%$

20,00%$

30,00%$

40,00%$

50,00%$

60,00%$

never$(0%)$

seldom$(<30%)$

o7en$(>70%)$

mixed$(30<50%)$

always$(100%)$

Percen

t'of'a

nswers'

The'kinds'of'my'grants'

public$compeDDve$

private$compeDDve$

contracts$with$public$bodies$

contracts$with$private$bodies$

RESEARCH OBJECTIVES  

8,51%&

12,77%&

31,91%&

40,43%&

4,26%&

0%& 10%& 20%& 30%& 40%&

absent&

I&have&mild&shortage,&but&no&research&ac@vi@es&disrup@on&

I&have&shortage,&but&I&compensate&with&collabora@ons&

I&have&severe&shortage,&so&I&must&limit&my&research&poten@al&

very&severe,&so&I&cannot&do&experimental&research&alone&or&in&collabora@on&

How$severe$is$your$shortage$of$funds?$

RESEARCH CHALLENGES  

9,09%%

15,91%%

18,18%%

56,82%%

4,55%%

0%% 10%% 20%% 30%% 40%% 50%% 60%%

I%have%no%needs%(I%have%staff)–%

I%need%one%PhD%fellow–%

I%need%one%postAdoc%fellow–%

I%need%one%PhD%and%one%postAdoc%fellow–%

I%need%2%postAdoc%fellows–%

How$much$staff$do$you$need?$

14,58%'

41,67%'

8,33%'

18,75%'

10,42%'

0%' 10%' 20%' 30%' 40%' 50%'

No'shortage'

Mild'shortage'(I'compensate'by'doing'some'administraBve'work)''

Medium'shortage'(I'compensate'by'external'support)'

Severe'shortage'(I'must'limit'my'research'grant'applicaBon'potenBal)'

Very'severe'(I'cannot'be'Lead'Partner)'

Are$you$short$of$administra1ve$support?$

0,00%$

0,00%$

21,74%$

50,00%$

30,43%$

0%$ 10%$ 20%$ 30%$ 40%$ 50%$

never$

preferably$not$

rarely$

o7en$

always$

How$do$you$bypass$the$factors$(funds,$research$and$administra7ve$staff)$that$challenge$your$

research?$BY$COLLABORATIONS$

0%#

10%#

20%#

30%#

40%#

50%#

absolutely#no#

preferably#no#

neutral#

preferably#yes#

absolutely#yes#

0,00%# 2,22%#

28,89%#35,56%#

33,33%#

0,00%# 2,33%#11,63%#

48,84%#

37,21%#

Do#you#like#to#be#a#Project#Partner?#

In#a#small#project#(3@5#Partners)#

In#a#large#project#(8@12#Partners)#

0%#

10%#

20%#

30%#

40%#

50%#

absolutely#no#

preferably#no#

neutral#

preferably#yes#

absolutely#yes#

9,09%#

20,45%#

43,18%#

18,18%#

9,09%#

21,43%#

47,62%#

21,43%#

4,76%# 4,76%#

Do#you#like#to#be#the#Lead#partner?#

In#a#small#project#(3@5#Partners)#

In#a#large#project#(8@12#Partners)#

Considerations  This could be steered by the Interreg Programme Authorities: •  The projects calls could be clear in defining not

only WHAT is the ultimate goal of a given Programme but also HOW. –  comprehensive strategic projects can support the the

thematic projects. –  some strategic projects could be quite complementary

to some tasks of the Technical Secretariats –  thematic projects (rather than the strategic ones) are

definitely more fitting than strategic ones to our biomedical research community.

Transregional Network for Innovation and Technology Transfer to Improve Health CareRete transregionale per l’innovazione ed il trasferimento tecnologico per il miglioramento della sanitàTransregionalno omrežje za inovacijo in prenos tehnološkega znanja za izboljšanje zdravstva

ProgeSo   Rete   Transregionale   per   l’innovazione   ed   il   Trasferimento   Tecnologico   per   il  Miglioramento   della   Sanità   finanziato   nell’ambito   del   Programma   per   la   Cooperazione  Transfrontaliera  Italia-­‐Slovenia  2007-­‐2013,  dal  Fondo  europeo  di  sviluppo  regionale  e  dai  fondi  nazionali.  Projekt   Transregionalno   omrežje   za   inovacijo   in   prenos   tehnološkega   znanja   za   izboljšanje  zdravstva  sofinancirana  v  okviru  Programa  čezmejnega  sodelovanja  Slovenija-­‐Italija  2007-­‐2013  iz  sredstev  Evropskega  sklada  za  regionalni  razvoj  in  nacionalnih  sredstev.

Thank you for your attention

Partners:   LP   –   Università   degli   Studi   di   Trieste,   PP1   –   Kemijski   InšBtut   Ljubljana,   PP1   –   Kemijski   InšBtut   Ljubljana,   PP2   –   Scuola  Internazionale  Superiore  di  Studi  AvanzaB,  PP3  –  Univerza  v  Novi  Gorici,  PP4  –  Università  di  Ferrara,  PP5  –  Treviso  Tecnologia,  PP6  –  Splošna  Bolnišnica  Dr.  Franca  Derganca,  PP7  –  Università  Ca’  Foscari  di  Venezia,  PP8  –  Università  di  Udine,  PP9  –  IRCCS  Burlo  Garofalo,  PP10  –  Zavod  Republike  Slovenije  Za  Transfuzijsko  Medicino,  PP11  –  Ortopedska  Bolnišnica  Valdoltra,  PP12  –  Univerza  na  Primorskem  -­‐  Fakulteta  za  Vede  o  Zdravju.  

!

Sabina Passamonti, MD, PhD University of Trieste

[email protected] +393665898629